REALQUALITY ResP-Aria

Description

The REALQUALITY ResP-ARIA kit is an IVD indicated for the identification of respiratory viruses severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Influenza A, Influenza B and respiratory syncytial virus (RSV) by one-step Real time RT-PCR

Product Characteristics

• The kit includes all reagents for reverse transcription and Real-Time PCR amplification
• It involves a single multiplex reaction for the amplification of respiratory viruses SARS-CoV-2, Influenza A, Influenza B, RSV and the endogenous internal control
• It is validated with RNA extracted from extracted from various samples types
• Requires 10 µL of extracted RNA
• Includes dUTP/UNG system for contamination prevention
• Requires an amplification time of 70 min
• It includes an automatic interpretation of results with AB Genius Report software
• It is validated on main Real time PCR instruments
• It is also available in automatic version on GENEQUALITY® automatic platforms

Kit content

Kit content:

• Ready-to-use reagents for reverse transcription and Real time PCR amplification
• Positive control
• Internal control

Further Information

Severe acute respiratory syndrome virus 2 (SARS-CoV-2), was first identified in Wuhan (China) in December 2019.
The transmission occurs through direct contact with infected people, through saliva, coughing or sneezing, and indirectly, through contaminated objects or surfaces; generally, the incubation period ranges from 2 to 14 days.
Patients affected by COVID-19 manifest symptoms that are often indistinguishable from those produced by other respiratory viruses such as Influenza A and B and respiratory syncytial virus (RSV); however, the management of these patients, in the current contingency, is much more complex and impacting on a health, social and economic level.
A timely differential diagnosis is therefore necessary to identify the most suitable therapeutic treatment early and, at the same time, to contain the spread of SARS-CoV-2, defining the modalities of a possible hospitalization and those of a subsequent reintegration of the patient in the family context and working.

Ordering Information